TrialBritish journal of haematology2015

A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study.

Terzah M Horton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.